首页> 外文期刊>Urology >Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer.
【24h】

Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer.

机译:紫杉醇和卡铂多药化疗后晚期阴茎癌患者的主要肿瘤消退。

获取原文
获取原文并翻译 | 示例
           

摘要

Penile cancer is rare in Western countries. High-risk patients are considered for prophylactic inguinal lymphadenectomy. For advanced disease, a triplet drug regimen consisting of bleomycin, methotrexate, and cisplatin is the most active combination tested so far. A 62-year-old man with penile cancer underwent partial penile amputation but presented 10 months later with inguinal nodal metastasis. He received three cycles of paclitaxel/carboplatin with marked clinical and radiologic (computed tomography and positron emission tomography) tumor regression. Later, complete resection of the inguinal nodal metastasis was performed. The paclitaxel/carboplatin combination has potential activity in penile cancer. Positron emission tomography may be used for screening of nodal metastases.
机译:阴茎癌在西方国家很少见。高危患者考虑进行预防性腹股沟淋巴结清扫术。对于晚期疾病,由博来霉素,甲氨蝶呤和顺铂组成的三联体药物治疗方案是迄今为止测试的最有效的组合。一名患有阴茎癌的62岁男子接受了部分阴茎切除术,但在10个月后出现腹股沟淋巴结转移。他接受了紫杉醇/卡铂的三个疗程,具有明显的临床和影像学(计算机断层扫描和正电子发射断层扫描)肿瘤消退。后来,彻底切除了腹股沟淋巴结转移。紫杉醇/卡铂组合在阴茎癌中具有潜在活性。正电子发射断层扫描可用于淋巴结转移的筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号